Insmed Incorporated: shareholders and insiders

INSMNASDAQHealthcare · Pharmaceutical Preparations

Price

$144.46

November 19, 2026Market cap $31.1B

What Ploutos Investor adds for Insmed

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 16 fiscal years, from 2009
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.

Insiders and their shares

Purchases and sales by officers and directors, from their own Form 4 filings.

Reading the newest filings from the SEC. This part fills in on its own in a few seconds.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

3 Holders over 5%Aug 14, 2026 Latest filing
  • FMRwith 1 more person
    Share of class7.40%
  • BlackRock, Inc.
    Share of class6.60%
  • Vanguard Capital Management
    Share of class5.34%
Fell to 5% or less (4)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Darwin Global Management, Ltd.3.00%Aug 14, 202613G/A
  • JPMorgan Chase4.70%Jul 22, 202613G/A
  • The Vanguard Group0.00%Mar 27, 202613G/A
  • T. Rowe Price Associates, Inc.3.30%Nov 14, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Duquesne (Druckenmiller)
    In the quarter+23%
  • D.E. Shaw
    In the quarter+4.5%
  • Bridgewater (Dalio)
    In the quarter+54%
  • Citadel Advisors (Griffin)
    In the quarter+17%
  • Millennium Mgmt (Englander)
    In the quarter+77%
  • Point72 (Cohen)
    In the quarter
  • Renaissance Technologies
    In the quarter
  • AQR Capital
    In the quarter-9.3%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 6.25% of its shares outstanding were held short, -2.3% since the report before.

Shares held short
13.48M
6.25%
Since the report before13.80M on Sep 30, 2026
-2.3%
4.1
3.26M
More days to cover thanof 4,578 US-listed companies with enough volume
50%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 15.44M
  • Nov 15, 2023: Shares held short 14.17M
  • Nov 30, 2023: Shares held short 12.13M
  • Dec 15, 2023: Shares held short 12.13M
  • Dec 29, 2023: Shares held short 10.32M
  • Jan 12, 2024: Shares held short 9.52M
  • Jan 31, 2024: Shares held short 10.39M
  • Feb 15, 2024: Shares held short 9.23M
  • Feb 29, 2024: Shares held short 8.57M
  • Mar 15, 2024: Shares held short 8.84M
  • Mar 28, 2024: Shares held short 9.04M
  • Apr 15, 2024: Shares held short 9.40M
  • Apr 30, 2024: Shares held short 8.53M
  • May 15, 2024: Shares held short 9.93M
  • May 31, 2024: Shares held short 10.86M
  • Jun 14, 2024: Shares held short 11.57M
  • Jun 28, 2024: Shares held short 12.83M
  • Jul 15, 2024: Shares held short 14.87M
  • Jul 31, 2024: Shares held short 13.69M
  • Aug 15, 2024: Shares held short 13.50M
  • Aug 30, 2024: Shares held short 12.23M
  • Sep 13, 2024: Shares held short 12.22M
  • Sep 30, 2024: Shares held short 13.20M
  • Oct 15, 2024: Shares held short 13.70M
  • Oct 31, 2024: Shares held short 13.85M
  • Nov 15, 2024: Shares held short 12.10M
  • Nov 29, 2024: Shares held short 12.62M
  • Dec 13, 2024: Shares held short 13.01M
  • Dec 31, 2024: Shares held short 15.44M
  • Jan 15, 2025: Shares held short 15.09M
  • Jan 31, 2025: Shares held short 14.54M
  • Feb 14, 2025: Shares held short 14.46M
  • Feb 28, 2025: Shares held short 14.62M
  • Mar 14, 2025: Shares held short 14.47M
  • Mar 31, 2025: Shares held short 14.50M
  • Apr 15, 2025: Shares held short 15.12M
  • Apr 30, 2025: Shares held short 15.78M
  • May 15, 2025: Shares held short 16.47M
  • May 30, 2025: Shares held short 17.46M
  • Jun 13, 2025: Shares held short 11.65M
  • Jun 30, 2025: Shares held short 9.80M
  • Jul 15, 2025: Shares held short 9.69M
  • Jul 31, 2025: Shares held short 9.54M
  • Aug 15, 2025: Shares held short 10.50M
  • Aug 29, 2025: Shares held short 10.56M
  • Sep 15, 2025: Shares held short 10.58M
  • Sep 30, 2025: Shares held short 10.73M
  • Oct 15, 2025: Shares held short 9.48M
  • Oct 31, 2025: Shares held short 8.03M
  • Nov 14, 2025: Shares held short 8.93M
  • Nov 28, 2025: Shares held short 9.87M
  • Dec 15, 2025: Shares held short 8.93M
  • Dec 31, 2025: Shares held short 11.02M
  • Jan 15, 2026: Shares held short 11.89M
  • Jan 30, 2026: Shares held short 11.70M
  • Feb 13, 2026: Shares held short 11.49M
  • Feb 27, 2026: Shares held short 11.28M
  • Mar 13, 2026: Shares held short 10.04M
  • Mar 31, 2026: Shares held short 13.76M
  • Apr 15, 2026: Shares held short 13.86M
  • Apr 30, 2026: Shares held short 14.71M
  • May 15, 2026: Shares held short 17.61M
  • May 29, 2026: Shares held short 19.13M
  • Jun 15, 2026: Shares held short 18.65M
  • Jun 30, 2026: Shares held short 16.03M
  • Jul 15, 2026: Shares held short 11.62M
  • Jul 31, 2026: Shares held short 11.35M
  • Aug 14, 2026: Shares held short 10.89M
  • Aug 31, 2026: Shares held short 11.44M
  • Sep 15, 2026: Shares held short 10.80M
  • Sep 30, 2026: Shares held short 13.80M
  • Oct 15, 2026: Shares held short 13.48M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading43.2% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 43.2% of the shares in the reported trades were short sales, against 39.2% in the 14 before.

Last 14 sessionsOct 30, 2026 – Nov 18, 2026
43.2%
The 14 beforeOct 12, 2026 – Oct 29, 2026
39.2%
Change
+4.0 pts
Short sales a dayon average, of 1.18M shares
510.3K
More than atof 3,656 US-listed companies, same days
28%
Median of alleight in ten from 34.4% to 63.7%
50.3%
  • Oct 12, 2026: Short sales 38.3%
  • Oct 13, 2026: Short sales 46.2%
  • Oct 14, 2026: Short sales 40.5%
  • Oct 15, 2026: Short sales 47.3%
  • Oct 16, 2026: Short sales 29.9%
  • Oct 19, 2026: Short sales 21.9%
  • Oct 20, 2026: Short sales 40%
  • Oct 21, 2026: Short sales 28.9%
  • Oct 22, 2026: Short sales 25.7%
  • Oct 23, 2026: Short sales 47%
  • Oct 26, 2026: Short sales 51.2%
  • Oct 27, 2026: Short sales 37.6%
  • Oct 28, 2026: Short sales 47.8%
  • Oct 29, 2026: Short sales 37.1%
  • Oct 30, 2026: Short sales 45.4%
  • Nov 2, 2026: Short sales 49.4%
  • Nov 3, 2026: Short sales 29.9%
  • Nov 4, 2026: Short sales 37.7%
  • Nov 5, 2026: Short sales 57.1%
  • Nov 6, 2026: Short sales 58.2%
  • Nov 9, 2026: Short sales 45.7%
  • Nov 10, 2026: Short sales 34.6%
  • Nov 11, 2026: Short sales 42.1%
  • Nov 12, 2026: Short sales 49.4%
  • Nov 13, 2026: Short sales 49.9%
  • Nov 16, 2026: Short sales 32.2%
  • Nov 17, 2026: Short sales 37%
  • Nov 18, 2026: Short sales 40.7%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

39 ETFs holding it1.78% The largest weight (IBB)
  • IBBiShares Biotechnology ETF
    Weight in the fund1.78%
  • XBIState Street(R) SPDR(R) S&P(R) Biotech ETF
    Weight in the fund1.08%
  • LABUDirexion Daily S&P Biotech Bull 3X Shares
    Weight in the fund0.73%
  • IWPiShares Russell Mid-Cap Growth ETF
    Weight in the fund0.63%
  • JGROJPMorgan Active Growth ETF
    Weight in the fund0.45%
  • VHTVanguard Health Care Index Fund
    Weight in the fund0.36%
  • IYHiShares U.S. Healthcare ETF
    Weight in the fund0.35%
  • VBKVanguard Small-Cap Growth Index Fund
    Weight in the fund0.33%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.27%
  • CGGRCapital Group Growth ETF
    Weight in the fund0.26%

39 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

666 Managers, Q2 2026$23.9B Value of their positions
  • Q3 2025: Managers 568
  • Q4 2025: Managers 678
  • Q1 2026: Managers 678
  • Q2 2026: Managers 666

Institutional investors by quarter

The fund managers holding INSM, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 666 managers held 224M shares, worth $23.9B. During the quarter 118 opened a position, 130 closed one, 241 added and 228 trimmed.

The largest holders, Q2 2026

  • FMR
    In the quarter+23%
  • BlackRock
    In the quarter-5.2%
  • JPMorgan Chase
    In the quarter-57%
  • Vanguard Portfolio Management
    In the quarter+0.3%
  • Vanguard Capital Management
    In the quarter+1.5%
  • Baker Bros. Advisors
    In the quarter+19%
  • Capital International Investors
    In the quarter+47%
  • Darwin Global Management
    In the quarter-62%
  • Ameriprise Financial
    In the quarter+102%
  • Orbis Allan Gray
    In the quarter+224%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Insmed's filings show?

Who buys and sells is one part of Insmed's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about INSM's shareholders

Didn't find what you were looking for?

Ask us
Which well-known managers hold INSM?

8 of the managers we track held the shares on Sep 30, 2026. The largest position was D.E. Shaw's, worth $627M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.